Intervention
C-11 PiB
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownMolecular and Structural Imaging in Alzheimer's Disease: A Longitudinal StudyNCT02740634 · 2016-05-01
RECRUITINGClinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersNCT04680130 · 2020-11-01
ENROLLING_BY_INVITATIONAmyloid-related Imaging Abnormalities (Microbleeds) in Atypical ADNCT01723553 · 2012-11-01
COMPLETEDNormative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young AdultsNCT01609335 · 2012-07-01
COMPLETEDCommon conditions
Posterior Cortical Atrophy (PCA)2Alzheimer Disease1Alzheimer Disease, Early Onset1Alzheimer's Disease1Amnestic Disorder1Amnestic Mild Cognitive Disorder1Amnestic Symptoms1Apraxia of Speech1Atypical Alzheimer's Disease1Atypical Alzheimers Disease1Behavioral Variant of Frontotemporal Dementia1CBD1FTD1Logopenic Progressive Aphasia (LPA)1Logopenic Variant of Primary Progressive Aphasia (LPA)1LPA1MSA - Multiple System Atrophy1Parkinson Disease1PCA1PPA1PSP1Semantic Aphasia1Semantic Dementia1
Leading sponsors
Trial status mix
COMPLETED2
ENROLLING_BY_INVITATION1
RECRUITING1
Phase mix
PHASE12
NA1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.